Skip to content
Subscriber Only
Business

Sanders Takes Aim at Insulin Makers in Latest Price Attack

  • Eli Lilly shares briefly drop after tweet by senator
  • Sanders say Lilly, Novo Nordisk making ‘outrageous profits’
Senator Bernie Sanders.

Senator Bernie Sanders.

Photographer: David Paul Morris/Bloomberg
Updated on

Makers of insulin became the latest target for Senator Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.

Shares of Eli Lilly & Co. fell after the senator, an independent lawmaker from Vermont, criticized the company and Novo Nordisk A/S over the price of insulin. Along with France’s Sanofi, they are among the world’s largest producers of the drugs, which are used by millions of diabetics.